HNB
PCVX icon

Huntington National Bank’s Vaxcyte PCVX Stock Holding History

Huntington National Bank’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.4K Hold
369
– – ﹤0.01% 1624
2025
Q4 		$17K Hold
369
– – ﹤0.01% 1632
2025
Q3 		$13.3K Buy
369
+217
+143% +$7.19K ﹤0.01% 1740
2025
Q2 		$4.94K Sell
152
-16
-10% -$525 ﹤0.01% 2008
2025
Q1 		$6.34K Buy
168
+16
+11% +$1.28K ﹤0.01% 1907
2024
Q4 		$12.4K Buy
152
+5
+3% +$496 ﹤0.01% 1697
2024
Q3 		$16.8K Buy
147
+124
+539% +$11.2K ﹤0.01% 1568
2024
Q2 		$1.74K Buy
23
+18
+360% +$1.23K ﹤0.01% 2192
2024
Q1 		$342 Buy
+5
New +$346 ﹤0.01% 2386
2023
Q4 		– Sell
-18
Closed -$918 – 3977
2023
Q3 		$918 Buy
+18
New +$888 ﹤0.01% 2222

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return